Natera, Inc.·4

Mar 10, 9:05 PM ET

RABINOWITZ DANIEL 4

4 · Natera, Inc. · Filed Mar 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Natera (NTRA) Sec. & Chief Legal Officer Daniel Rabinowitz Sells Shares

What Happened

  • Daniel Rabinowitz, Natera's Secretary and Chief Legal Officer, exercised 5,598 option shares on March 6, 2026, paying $19.68 per share for a total exercise cost of $110,169 (reported as an "M" exercise). On the same date he sold a total of 8,398 shares in multiple open-market transactions, generating aggregate proceeds of about $1,646,696. The filing also reports a derivative-related disposal of 5,598 shares at $0.00 (see Key Details for note).

Key Details

  • Transaction date: March 6, 2026; Form 4 filed March 10, 2026 (filed within the required two business days).
  • Option exercise: 5,598 shares acquired at $19.68 each (total $110,169).
  • Open-market sales (total 8,398 shares) by group:
    • 400 shares at a weighted avg $193.73 (proceeds $77,491) — prices ranged $193.27–$194.02 (F2)
    • 2,900 shares at $194.77 (proceeds $564,832) — prices ranged $194.27–$195.25 (F3)
    • 1,600 shares at $195.80 (proceeds $313,273) — prices ranged $195.32–$196.26 (F4)
    • 1,500 shares at $196.94 (proceeds $295,406) — prices ranged $196.42–$197.38 (F5)
    • 1,998 shares at $198.04 (proceeds $395,694) — prices ranged $197.45–$198.32 (F6)
  • Reported aggregate proceeds from sales: ~$1,646,696.
  • The filing lists a disposal of 5,598 shares at $0.00 under the derivative code (M); filings often report such $0 disposals when shares are surrendered or withheld in connection with an option exercise (e.g., to cover exercise cost or tax withholding), but the filing does not provide further detail here.
  • Footnotes: sales were effected pursuant to a Rule 10b5-1 trading plan adopted Dec 5, 2025 (F1). F7 notes the option shares are fully exercisable.
  • Shares owned after the transactions are not disclosed in the information you provided in this summary.

Context

  • This filing shows an option exercise paired with sizable open-market sales executed under a pre-established 10b5-1 plan. Exercises followed by immediate or near-term sales are common liquidity events for insiders and do not, by themselves, indicate a change in view about the company’s prospects.
  • Derivative entries on Form 4 can include both the option exercise (acquisition) and shares surrendered/withheld (reported as disposals at $0.00); the filing here includes both types.

Insider Transaction Report

Form 4
Period: 2026-03-06
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-06$19.68/sh+5,598$110,169241,683 total
  • Sale

    Common Stock

    [F1][F2]
    2026-03-06$193.73/sh400$77,491241,283 total
  • Sale

    Common Stock

    [F1][F3]
    2026-03-06$194.77/sh2,900$564,832238,383 total
  • Sale

    Common Stock

    [F1][F4]
    2026-03-06$195.80/sh1,600$313,273236,783 total
  • Sale

    Common Stock

    [F1][F5]
    2026-03-06$196.94/sh1,500$295,406235,283 total
  • Sale

    Common Stock

    [F1][F6]
    2026-03-06$198.04/sh1,998$395,694233,285 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F7]
    2026-03-065,5980 total
    Exercise: $19.68Exp: 2029-03-21Common Stock (5,598 underlying)
Footnotes (7)
  • [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.27 to $194.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.27 to $195.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.32 to $196.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.42 to $197.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.45 to $198.32 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The option shares are fully exercisable.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-03-10

Documents

1 file
  • 4
    form4-03102026_090301.xmlPrimary